Rexahn Pharmaceuticals Inc.
Synthesis and anticancer activity of new 1-[(5 or 6-substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-hetero)arylpiperazine derivatives.
(Bioorganic & Medicinal Chemistry, November 2010, 18(22,15), 7966-7974)[Link]
Development of 3-aryl-1-isoquinolinamines as potent antitumor agents based on CoMFA.
(European Journal of Medicinal Chemistry, November 2010, 45(11), 5493-5497)[Link]
Synthesis, in vitro and in vivo evaluation of 3-arylisoquinolinamines as potent antitumor agents.
(Bioorganic & Medicinal Chemistry Letters, September 2010 20(17,1), 5277-5281)[Link]
Clavulanic Acid Protects Neurons in Pharmacological Models of Neurodegenerative Diseases.
(Drug Development Research September 2010, 71(6), 351–357)[Link]
Antitumor activity of a novel antisense oligonucleotide against Akt1.
(Journal of Cellular Biochemistry, November 2009, 108(4) 832–838) [Link]
Clavulanic acid: A competitive inhibitor of beta-lactamases with novel anxiolytic-like activity and minimal side effects.
(Pharmacology Biochemistry and Behavior, August 2009, 93(2), 112-120)[Link]
Clavulanic acid stimulates sexual behaviour in male rats.
(European Journal of Pharmacology, May 2009, 609(1-3), 69-73)[Link]
QSID Tool: a new three-dimensional QSAR environmental tool.
(Journal of Computer-Aided Molecular Design, December 2008, 22(12), 873-883)[Link]
In Vivo and In Vitro Effects of a HIF-1a Inhibitor,RX-0047.
(Journal of Cellular Biochemistry, June 2008, 104(3), 985–994)[Link]
SYNTHESIS AND ANTITUMOR ACTIVITY OF FLUOROCYCLOPENTENYL-PYRIMIDINES.
(Nucleosides Nucleotides Nucleic Acids, 2007, 26(6-7), 713-6)[Link]
Requirement of hCenexin for Proper Mitotic Functions of Polo-Like Kinase 1 at the Centrosomes.
(Molecular and Cellular Biology, November 2006, 26(22), 8316-8335)[Link]
Design, synthesis, and anticancer activity of fluorocyclopentenyl-pyrimidines.
(Nucleic Acids Symp Ser, September 2005, 49(1), 107-108)[Link]
